HOME >> BIOLOGY >> NEWS
Jefferson Scientists Hopeful That Understanding Tumor-Suppressor Protein Function May Someday Lead To Treatment

Scientists at Jefferson Medical College of Thomas Jefferson University in Philadelphia appear to have an important clue to the workings of a gene that normally protects against cancer. Ultimately, by understanding how both the normal and the damaged gene work, scientists may be able to find ways to interfere with the development of cancer.

Charles Brenner, Ph.D., assistant professor of microbiology and immunology, and a member of Jefferson's Kimmel Cancer Center, and his colleagues at the University of Texas in San Antonio, and at the University of Sheffield in England, have distinguished between potential mechanisms by which the FHIT gene works in preventing cancer development.

A report of the researchers' work appears May 12 in the Proceedings of the National Academy of Sciences.

Dr. Brenner and his colleagues used a combined genetic, biochemical and crystallographic approach to gain information about the function of the tumor-suppressor protein, Fhit, the product of the FHIT gene.

According to Dr. Brenner, Fhit is "encoded in the most fragile site of the human genome. The FHIT gene is frequently inactivated early in the development of cancer, especially in lung cancer."

Dr. Brenner and his co-workers sought to understand how the Fhit protein suppresses tumor formation. "We knew that the Fhit protein is an enzyme that binds and cleaves an unusual class of nucleotides in the cell, called ApppA," he explains. "We wanted to determine if the important function of Fhit was to cleave ApppA or signal the presence of this compound in the cell in order to put the brakes on cell growth." Tumors form when the Fhit protein is absent.

New experiments showed that altered forms of the Fhit protein that bind but don't cleave ApppA are actually still working in tumor suppression. "That excluded the idea that the important thing that Fhit
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-6300
Thomas Jefferson University
11-May-1998


Page: 1 2

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
5. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
6. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
7. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
8. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
9. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
10. Jefferson scientists use gene repair technique to change albino mice hairs to black
11. Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/19/2018)... ROCHELLE, Va. (PRWEB) , ... December 19, 2018 , ... ... former Scientific Reviewer and Compliance Officer at the FDA Center for Devices and Radiological ... with NDA Partners as an Expert Consultant since 2015, and she has more than ...
(Date:12/18/2018)... ... December 18, 2018 , ... The nation’s leader in ... marketing. The technology has been effective at reducing patient acquisition costs by over ... with clients nationwide on patient acquisition marketing programs. Traditional marketing for stem cell ...
(Date:12/14/2018)... (PRWEB) , ... December 14, 2018 , ... ... patent number 9,703,929 entitled “Method and System for Microbiome-Derived Diagnostics and Therapeutics” by ... date of October 21, 2014. The patent is an invention by uBiome collaborators ...
Breaking Biology News(10 mins):
(Date:1/4/2019)... N.C. (PRWEB) , ... January 04, 2019 , ... ... is pleased to welcome Ted Hoffman to the firm. Ted will be joining ... of experience working in and providing consulting services to the pharmaceutical industry. At ...
(Date:12/20/2018)... ... December 20, 2018 , ... New Year’s brings reflection and desire to ... in the European Union (EU) on the horizon, Jim Kasic, president and CEO of ... to the EU Medical Device Regulation (MDR), digital health, and big data are just ...
(Date:12/18/2018)... ... December 18, 2018 , ... USDM Life Sciences, the ... sciences industry, unveiled a completely redesigned website at http://www.usdm.com . The site ... for their valued clients and business partners. , The website has a ...
(Date:12/13/2018)... (PRWEB) , ... December 12, 2018 , ... ... other life science software solutions, announces the Limfinity® ML (Machine Learning) addition for ... trained machine learning models within Limfinity® solutions. In the module, trained models make ...
Breaking Biology Technology:
Cached News: